4.7 Article

Effects of HuangKui capsules on glibenclamide pharmacokinetics in rats

期刊

JOURNAL OF ETHNOPHARMACOLOGY
卷 139, 期 1, 页码 1-5

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2011.03.043

关键词

HuangKui capsules; Glibenclamide; Pharmacokinetics; LC-MS/MS; Plasma

资金

  1. Key Technologies Research and Development Program of China [2006BAI14B07]

向作者/读者索取更多资源

Ethnopharmacology: The main components of HuangKui capsules' are the total flavonoids extracted from the flowers of Abelmoschus manihot L medic. They have been widely used to treat chronic glomerulonephritis, diabetic nephropathy and nephrotic syndrome. The combination of HuangKui capsules and glibenclamide is a possible therapy for patients with diabetes mellitus and diabetic nephropathy. However, there is no report about effects of HuangKui capsules on the glibenclamide pharmacokinetics till now. Aim of the study: This study was aimed investigating the effect of HuangKui capsules on pharmacokinetics of glibenclamide in rats. Material and methods: Eight rats were administered with an oral dose of HuangKui capsules (0.75 g kg(-1)) once daily for 10 consecutive days. All the rats were administered orally with the glibenclamide (1 mg kg(-1)) before the first time and after the last time given HuangKui capsules. LC-MS/MS was utilized to determine the concentration of glibenclamide in rat plasma and to calculate the corresponding pharmacokinetic parameters. The statistical differences of the two cycles were evaluated by paired-samples t-test. Results: In the rats treated with HuangKui capsules and glibenclamide, the t(1/2), the time point of maximum plasma concentration (T-max) of glibenclamide increased obviously (p < 0.05) compared with the glibenclamide alone, while maximum plasma concentrations (C-max), area under the plasma concentration-time curve (AUC((0-t)) decreased significantly (p < 0.05). There was no significant difference between other parameters. Conclusion: HuangKui capsules can reduce the absorption of glibenclamide and accelerate the metabolism of glibenclamide. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据